Cargando…

4-Amino-N-(2,3-di­hydro-1,3-thia­zol-2-yl­idene)benzene­sulfonamide–2,4,6-tris­(pyr­idin-2-yl)-1,3,5-triazine (1/1)

The sulfa­thia­zole mol­ecule in the title 1:1 co-crystal, C(9)H(9)N(3)O(2)S(2)·C(18)H(12)N(6), adopts an approximate L-shape [dihedral angle between the five- and six-membered rings = 86.20 (9)°] and features an intra­molecular hypervalent S⋯O inter­action [2.8666 (15) Å]. Overall, the triazine mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Arman, Hadi D., Kaulgud, Trupta, Tiekink, Edward R. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998630/
https://www.ncbi.nlm.nih.gov/pubmed/24826120
http://dx.doi.org/10.1107/S1600536814004838
_version_ 1782313403731148800
author Arman, Hadi D.
Kaulgud, Trupta
Tiekink, Edward R. T.
author_facet Arman, Hadi D.
Kaulgud, Trupta
Tiekink, Edward R. T.
author_sort Arman, Hadi D.
collection PubMed
description The sulfa­thia­zole mol­ecule in the title 1:1 co-crystal, C(9)H(9)N(3)O(2)S(2)·C(18)H(12)N(6), adopts an approximate L-shape [dihedral angle between the five- and six-membered rings = 86.20 (9)°] and features an intra­molecular hypervalent S⋯O inter­action [2.8666 (15) Å]. Overall, the triazine mol­ecule has the shape of a disk as the pendant pyridine rings are relatively close to coplanar with the central ring [dihedral angles = 18.35 (9), 6.12 (9) and 4.67 (9)°]. In the crystal packing, a linear supra­molecular chain aligned along [01-1] is formed as a result of amino–pyridyl N—H⋯N hydrogen bonding with syn-disposed pyridyl mol­ecules of one triazine, and amine–pyridyl N—H⋯N hydrogen bonding with the third pydridyl ring of a second triazine mol­ecule. A three-dimensional architecture arises as the chains are connected by C—H⋯O inter­actions.
format Online
Article
Text
id pubmed-3998630
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-39986302014-05-13 4-Amino-N-(2,3-di­hydro-1,3-thia­zol-2-yl­idene)benzene­sulfonamide–2,4,6-tris­(pyr­idin-2-yl)-1,3,5-triazine (1/1) Arman, Hadi D. Kaulgud, Trupta Tiekink, Edward R. T. Acta Crystallogr Sect E Struct Rep Online Organic Papers The sulfa­thia­zole mol­ecule in the title 1:1 co-crystal, C(9)H(9)N(3)O(2)S(2)·C(18)H(12)N(6), adopts an approximate L-shape [dihedral angle between the five- and six-membered rings = 86.20 (9)°] and features an intra­molecular hypervalent S⋯O inter­action [2.8666 (15) Å]. Overall, the triazine mol­ecule has the shape of a disk as the pendant pyridine rings are relatively close to coplanar with the central ring [dihedral angles = 18.35 (9), 6.12 (9) and 4.67 (9)°]. In the crystal packing, a linear supra­molecular chain aligned along [01-1] is formed as a result of amino–pyridyl N—H⋯N hydrogen bonding with syn-disposed pyridyl mol­ecules of one triazine, and amine–pyridyl N—H⋯N hydrogen bonding with the third pydridyl ring of a second triazine mol­ecule. A three-dimensional architecture arises as the chains are connected by C—H⋯O inter­actions. International Union of Crystallography 2014-03-08 /pmc/articles/PMC3998630/ /pubmed/24826120 http://dx.doi.org/10.1107/S1600536814004838 Text en © Arman et al. 2014 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Arman, Hadi D.
Kaulgud, Trupta
Tiekink, Edward R. T.
4-Amino-N-(2,3-di­hydro-1,3-thia­zol-2-yl­idene)benzene­sulfonamide–2,4,6-tris­(pyr­idin-2-yl)-1,3,5-triazine (1/1)
title 4-Amino-N-(2,3-di­hydro-1,3-thia­zol-2-yl­idene)benzene­sulfonamide–2,4,6-tris­(pyr­idin-2-yl)-1,3,5-triazine (1/1)
title_full 4-Amino-N-(2,3-di­hydro-1,3-thia­zol-2-yl­idene)benzene­sulfonamide–2,4,6-tris­(pyr­idin-2-yl)-1,3,5-triazine (1/1)
title_fullStr 4-Amino-N-(2,3-di­hydro-1,3-thia­zol-2-yl­idene)benzene­sulfonamide–2,4,6-tris­(pyr­idin-2-yl)-1,3,5-triazine (1/1)
title_full_unstemmed 4-Amino-N-(2,3-di­hydro-1,3-thia­zol-2-yl­idene)benzene­sulfonamide–2,4,6-tris­(pyr­idin-2-yl)-1,3,5-triazine (1/1)
title_short 4-Amino-N-(2,3-di­hydro-1,3-thia­zol-2-yl­idene)benzene­sulfonamide–2,4,6-tris­(pyr­idin-2-yl)-1,3,5-triazine (1/1)
title_sort 4-amino-n-(2,3-di­hydro-1,3-thia­zol-2-yl­idene)benzene­sulfonamide–2,4,6-tris­(pyr­idin-2-yl)-1,3,5-triazine (1/1)
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998630/
https://www.ncbi.nlm.nih.gov/pubmed/24826120
http://dx.doi.org/10.1107/S1600536814004838
work_keys_str_mv AT armanhadid 4aminon23dihydro13thiazol2ylidenebenzenesulfonamide246trispyridin2yl135triazine11
AT kaulgudtrupta 4aminon23dihydro13thiazol2ylidenebenzenesulfonamide246trispyridin2yl135triazine11
AT tiekinkedwardrt 4aminon23dihydro13thiazol2ylidenebenzenesulfonamide246trispyridin2yl135triazine11